Literature DB >> 19015075

Fatal pneumonitis induced by oxaliplatin.

Sara Arévalo Lobera1, Naiara Sagastibeltza Mariñelarena, Ibone Elejoste Echeberría, Mireia Melé Olivé, Larraitz Egaña Otaño, Laura Basterretxea Badiola, Adelaida La Casta Muñoa, Mikel Azkue Gabilondo.   

Abstract

Oxaliplatin has been approved for adjuvant treatment of colorectal cancer. Toxicity induced by oxaliplatin is moderate and manageable, but some isolated cases of severe pulmonary toxicity associated to oxaliplatin have been reported. Two fatal cases of interstitial pneumonitis rapidly evolving to pulmonary fibrosis are reported here.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19015075     DOI： 10.1007/s12094-008-0285-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  12 in total

1.  Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy.

Authors:  R Trisolini; L Lazzari Agli; D Tassinari; D Rondelli; A Cancellieri; M Patelli; F Falcone; V Poletti
Journal:  Eur Respir J       Date:  2001-07       Impact factor: 16.671

Review 2.  Cellular and molecular pharmacology of oxaliplatin.

Authors:  Eric Raymond; Sandrine Faivre; Stephen Chaney; Jan Woynarowski; Esteban Cvitkovic
Journal:  Mol Cancer Ther       Date:  2002-01       Impact factor: 6.261

3.  Peripheral neuropathy induced by oxaliplatin-based chemotherapy.

Authors: 
Journal:  J Support Oncol       Date:  2006-02

Review 4.  Thiol proteins, redox modulation and parenchymal lung disease.

Authors:  V L Kinnula; K Vuorinen; H Ilumets; P Rytilä; M Myllärniemi
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

5.  Is acute dyspnea related to oxaliplatin administration?

Authors:  L M Pasetto; S Monfardini
Journal:  World J Gastroenterol       Date:  2006-09-28       Impact factor: 5.742

6.  Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer.

Authors:  Ramesh K Ramanathan; Jeffery W Clark; Nancy E Kemeny; Heinz-Josef Lenz; Kim O Gococo; Daniel G Haller; Edith P Mitchell; Carl G Kardinal
Journal:  J Clin Oncol       Date:  2003-08-01       Impact factor: 44.544

7.  Cryptogenic organizing pneumonitis during oxaliplatin chemotherapy for colorectal cancer: case report.

Authors:  Marcelo Garrido; Andrés O'Brien; Sergio González; José Miguel Clavero; Eric Orellana
Journal:  Chest       Date:  2007-12       Impact factor: 9.410

8.  Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

Authors:  L Rubbia-Brandt; V Audard; P Sartoretti; A D Roth; C Brezault; M Le Charpentier; B Dousset; P Morel; O Soubrane; S Chaussade; G Mentha; B Terris
Journal:  Ann Oncol       Date:  2004-03       Impact factor: 32.976

9.  Exacerbation of pre-existing interstitial lung disease after oxaliplatin therapy: a report of three cases.

Authors:  Brad E Wilcox; Jay H Ryu; Sanjay Kalra
Journal:  Respir Med       Date:  2007-10-22       Impact factor: 3.415

10.  Eosinophilic lung disease under chemotherapy with oxaliplatin for colorectal cancer.

Authors:  Frederic Gagnadoux; Cecile Roiron; Emmanuelle Carrie; Laurence Monnier-Cholley; Bernard Lebeau
Journal:  Am J Clin Oncol       Date:  2002-08       Impact factor: 2.339
View more
  16 in total

1.  Interstitial lung disease associated with oxaliplatin: description of two cases.

Authors:  C Pena Alvarez; H J Suh Oh; A Sáenz de Miera Rodríguez; F R García Arroyo; M Covela Rúa; L Salgado Boquete; P M López Clemente; M Constenla Figueiras
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

2.  Fatal interstitial pneumonia associated with oxaliplatin-based therapy in a patient with metastatic rectal cancer.

Authors:  Satoshi Ishizone; Naohiko Koide; Noriyuki Akita; Fumitoshi Karasawa; Nobumitsu Kobayashi; Tomonobu Koizumi; Shinichi Miyagawa
Journal:  Clin J Gastroenterol       Date:  2011-03-24

3.  Oxaliplatin-induced lung injury with allergic reaction.

Authors:  Tetsuya Homma; Masatsugu Kurokawa; Yoshitaka Yamamoto; Satoshi Matsukura; Koushi Ieki; Shintaro Suzuki; Miho Odaka; Shin Watanabe; Munehiro Yamaguchi; Mitsuru Adachi
Journal:  Chin J Cancer Res       Date:  2011-09       Impact factor: 5.087

4.  Oxaliplatin-induced bronchiolitis obliterans organizing pneumonia following hyperthermic intraperitoneal chemotherapy.

Authors:  Guillaume Le Baut; Jean-Marc Guilloit; Vincent Leprince; Yann Ollivier; Catherine Dubos-Arvis; Pascal Do; Jasmine Sutter; Ludovic Loge; Radj Gervais
Journal:  J Gastrointest Oncol       Date:  2018-06

5.  Interstitial lung disease in a patient treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX) for metastatic colorectal cancer.

Authors:  Liam M Hannan; Jaclyn Yoong; Geoffrey Chong; Christine F McDonald
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

6.  Oxaliplatin-induced lung fibrosis.

Authors:  Arpan Shah; Zarir F Udwadia; Sachin Almel
Journal:  Indian J Med Paediatr Oncol       Date:  2009-07

7.  Oxaliplatin-induced Pulmonary Fibrosis: Two Case Reports.

Authors:  Chun-Geun Ryu; Eun-Joo Jung; Gangmi Kim; Su Ran Kim; Dae-Yong Hwang
Journal:  J Korean Soc Coloproctol       Date:  2011-10-31

8.  Fatal pneumonitis induced by oxaliplatin: description of three cases.

Authors:  L B Pontes; D P D Armentano; A Soares; R C Gansl
Journal:  Case Rep Oncol       Date:  2012-02-29

9.  Oxaliplatin-associated sarcoid-like reaction masquerading as recurrent colon cancer.

Authors:  Surya Kiran Aedma; Anusha Chidharla; Sarah Kelting; Anup Kasi
Journal:  BMJ Case Rep       Date:  2020-09-08

10.  Granulomatous lung disease requiring mechanical ventilation induced by a single application of oxaliplatin-based chemotherapy for colorectal cancer: a case report.

Authors:  Dane Wildner; Frank Boxberger; Axel Wein; Kerstin Wolff; Heinz Albrecht; Gudrun Männlein; Rolf Janka; Kerstin Amann; Jürgen Siebler; Werner Hohenberger; Markus F Neurath; Richard Strauß
Journal:  Case Rep Oncol Med       Date:  2013-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.